SELVITA S.A. SER.B ZY-80/ PLSLVCR00029 /
| 11/15/2024 7:57:05 AM | Chg. 0.0000 | Volume | Bid5:30:21 PM | Ask5:30:21 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 12.6800EUR | 0.00% | - Turnover: - |
11.7000Bid Size: 350 | 12.4600Ask Size: 350 | 218.11 mill.EUR | - | - |
Business description
-
Management board & Supervisory board
| CEO |
|---|
| Bogusław Sieczkowski |
| Management board |
| Bogusław Sieczkowski, Miłosz Gruca , Mirosława Zydroń, Dariusz Kurdas, Dawid Radziszewski, Adrijana Vinter |
| Supervisory board |
| Piotr Romanowski, Tadeusz Wesołowski, Rafał Chwast, Wojciech Chabasiewicz, Paweł Przewięźlikowski, Jacek Osowski |
Company data
| Name: | SELVITA S.A. |
| Address: | UL. BOBRZYŃSKIEGO 14,30-348 KRAKÓW |
| Phone: | +48 12 297 47 00 |
| Fax: | +48 12 297 47 01 |
| E-mail: | selvita@selvita.com |
| Internet: | https://selvita.com/ |
| Industry: | Healthcare |
| Sector: | Medical Products |
| Sub sector: | - |
| End of financial year: | 12/31 |
| Free Float: | 45.60% |
| IPO date: | 10/16/2019 |
Investor relations
| Name: | - |
| IR phone: | - |
| IR Fax: | - |
| IR e-mail: | ir@selvita.com |
Company calendar
| CW 47 | 11/21/2024 Interim Report 3rd Quarter/9 Months |
Main Shareholders
| Others | 52.27% | |
| Paweł Przewięźlikowski | 16.18% | |
| TFI Allianz Polska | 10.98% | |
| Nationale -Nederlanden Open-End Pension Fund | 10.36% | |
| Bogusław Sieczkowski | 5.13% | |
| Tadeusz Wesołowski (with Augebit FIZ) | 5.08% |
